Kolitz JE, George SL, Marcucci G, et al. P-glycoprotein inhibition using valspodar (PSC- 833) does not improve outcomes for patients younger than age 60 years with newly diagnosed acute myeloid leukemia. Cancer and Leukemia Group B study 19808.